Pharmacotherapy of comorbid mood, anxiety, and substance use disorders

被引：28

作者：

Brady, KT ^{[1
]}

Verduin, ML ^{[1
]}

机构：

[1] Med Univ S Carolina, Inst Psychiat, Charleston, SC 29425 USA

来源：

SUBSTANCE USE & MISUSE | 2005年 / 40卷 / 13-14期

关键词：

substance use; mood disorders; anxiety disorders; depression; bipolar disorder; panic disorder; post-traumatic stress disorder; obsessive compulsive disorder; social phobia; alcohol; cocaine; marijuana; opiates;

D O I：

10.1080/10826080500294924

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.

引用

页码：2021 / 2041

页数：21

共 50 条

[21] Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders
Melchior, Maria
Prokofyeva, Elena
Younes, Nadia
Surkan, Pamela J.
Martins, Silvia S.
[J]. BMC PSYCHIATRY, 2014, 14
[22] Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders
Maria Melchior
Elena Prokofyeva
Nadia Younès
Pamela J Surkan
Silvia S Martins
[J]. BMC Psychiatry, 14
[23] Treatment of Comorbid Substance Use and Anxiety Disorders A Case Study
Ries, Richard
Wolitzky-Taylor, Kate B.
Operskalski, Joachim T.
Craske, Michelle G.
Roy-Byrne, Peter
[J]. JOURNAL OF ADDICTION MEDICINE, 2011, 5 (04) : 248 - 253
[24] Pharmacotherapy and psychotherapy of comorbid anxiety disorders and alcoholism
Fedorova, S. S.
[J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (06) : 58 - 62
[25] Pharmacotherapy Options in Comorbid Bipolar Disorder and Alcohol-Substance Use Disorders
Altinbas, Kursat
Evren, Cuneyt
[J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 23 (04): : 378 - 389
[26] GENDER DIFFERENCES IN COMORBID ANXIETY AND MOOD DISORDERS
OCHOA, L
BECK, AT
STEER, RA
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1992, 149 (10): : 1409 - 1410
[27] Pharmacotherapy for Substance Use Disorders
Klein, Jared Wilson
[J]. MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (04) : 891 - +
[28] Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders
Liraud, F
Verdoux, H
[J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2002, 28 (02): : 160 - 168
[29] Evaluation of an integrated group cognitive-behavioral treatment for comorbid mood, anxiety, and substance use disorders: A pilot study
Milosevic, Irena
Chudzik, Susan M.
Boyd, Susan
McCabe, Randi E.
[J]. JOURNAL OF ANXIETY DISORDERS, 2017, 46 : 85 - 100
[30] Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach
Cheatle M.D.
Gallagher R.M.
[J]. Current Psychiatry Reports, 2006, 8 (5) : 371 - 376

← 1 2 3 4 5 →